$NPLS
NP Life Sciences Health Industry Group Inc.
Stock
$npls
2021 Form 10-K Financial Statement
#000149315222010074 Filed on April 15, 2022
Income Statement
Concept | 2021 | 2020 Q4 |
---|---|---|
Revenue | $30.00K | |
YoY Change | 50.0% | |
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | ||
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | $100.0K | |
YoY Change | -33.33% | |
% of Gross Profit | ||
Research & Development | ||
YoY Change | ||
% of Gross Profit | ||
Depreciation & Amortization | $0.00 | |
YoY Change | ||
% of Gross Profit | ||
Operating Expenses | $100.0K | |
YoY Change | -33.33% | |
Operating Profit | -$65.68K | |
YoY Change | ||
Interest Expense | $0.00 | |
YoY Change | ||
% of Operating Profit | ||
Other Income/Expense, Net | $4.00 | |
YoY Change | ||
Pretax Income | -$70.00K | |
YoY Change | -46.15% | |
Income Tax | ||
% Of Pretax Income | ||
Net Earnings | -$70.00K | |
YoY Change | -46.15% | |
Net Earnings / Revenue | -233.33% | |
Basic Earnings Per Share | ||
Diluted Earnings Per Share | -$1.629K | |
COMMON SHARES | ||
Basic Shares Outstanding | 42.96M shares | |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2021 | 2020 Q4 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $30.00K | |
YoY Change | -75.0% | |
Cash & Equivalents | $30.00K | $118.6K |
Short-Term Investments | ||
Other Short-Term Assets | $10.00K | |
YoY Change | ||
Inventory | ||
Prepaid Expenses | ||
Receivables | ||
Other Receivables | ||
Total Short-Term Assets | $40.00K | |
YoY Change | -66.67% | |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | ||
YoY Change | ||
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | ||
YoY Change | ||
Total Long-Term Assets | $0.00 | |
YoY Change | ||
TOTAL ASSETS | ||
Total Short-Term Assets | $40.00K | |
Total Long-Term Assets | $0.00 | |
Total Assets | $40.00K | |
YoY Change | -66.67% | |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $0.00 | |
YoY Change | ||
Accrued Expenses | $0.00 | |
YoY Change | -100.0% | |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $0.00 | |
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $0.00 | |
YoY Change | -100.0% | |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | |
YoY Change | ||
Other Long-Term Liabilities | ||
YoY Change | ||
Total Long-Term Liabilities | $0.00 | |
YoY Change | ||
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $0.00 | |
Total Long-Term Liabilities | $0.00 | |
Total Liabilities | $0.00 | |
YoY Change | -100.0% | |
SHAREHOLDERS EQUITY | ||
Retained Earnings | ||
YoY Change | ||
Common Stock | ||
YoY Change | ||
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $40.00K | $103.8K |
YoY Change | ||
Total Liabilities & Shareholders Equity | $40.00K | |
YoY Change | -66.67% |
Cashflow Statement
Concept | 2021 | 2020 Q4 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$70.00K | |
YoY Change | -46.15% | |
Depreciation, Depletion And Amortization | $0.00 | |
YoY Change | ||
Cash From Operating Activities | -$90.00K | |
YoY Change | -25.0% | |
INVESTING ACTIVITIES | ||
Capital Expenditures | ||
YoY Change | ||
Acquisitions | ||
YoY Change | ||
Other Investing Activities | ||
YoY Change | ||
Cash From Investing Activities | ||
YoY Change | ||
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | ||
YoY Change | ||
NET CHANGE | ||
Cash From Operating Activities | -90.00K | |
Cash From Investing Activities | ||
Cash From Financing Activities | ||
Net Change In Cash | -90.00K | |
YoY Change | -25.0% | |
FREE CASH FLOW | ||
Cash From Operating Activities | -$90.00K | |
Capital Expenditures | ||
Free Cash Flow | ||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2020Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
USD | |
CY2021Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
USD | |
CY2020Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
USD | |
CY2020Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2021 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
USD | |
CY2021 | us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
USD | |
CY2020 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
USD | |
CY2021 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
USD | |
CY2021 | us-gaap |
Interest Paid Net
InterestPaidNet
|
USD | |
CY2020 | us-gaap |
Interest Paid Net
InterestPaidNet
|
USD | |
CY2021 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
USD | |
CY2020 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
USD |